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Abstract
Background: We aimed at assessing the degree of measurement error in essential fatty acid
intakes from a food frequency questionnaire and the impact of correcting for such an error on
precision and bias of odds ratios in logistic models. To assess these impacts, and for illustrative
purposes, alternative approaches and methods were used with the binary outcome of cognitive
decline in verbal fluency.
Methods: Using the Atherosclerosis Risk in Communities (ARIC) study, we conducted a
sensitivity analysis. The error-prone exposure – visit 1 fatty acid intake (1987–89) – was available
for 7,814 subjects 50 years or older at baseline with complete data on cognitive decline between
visits 2 (1990–92) and 4 (1996–98). Our binary outcome of interest was clinically significant decline
in verbal fluency. Point estimates and 95% confidence intervals were compared between naïve and
measurement-error adjusted odds ratios of decline with every SD increase in fatty acid intake as %
of energy. Two approaches were explored for adjustment: (A) External validation against
biomarkers (plasma fatty acids in cholesteryl esters and phospholipids) and (B) Internal repeat
measurements at visits 2 and 3. The main difference between the two is that Approach B makes a
stronger assumption regarding lack of error correlations in the structural model. Additionally, we
compared results from regression calibration (RCAL) to those from simulation extrapolation
(SIMEX). Finally, using structural equations modeling, we estimated attenuation factors associated
with each dietary exposure to assess degree of measurement error in a bivariate scenario for
regression calibration of logistic regression model.
Results and conclusion: Attenuation factors for Approach A were smaller than B, suggesting a
larger amount of measurement error in the dietary exposure. Replicate measures (Approach B)
unlike concentration biomarkers (Approach A) may lead to imprecise odds ratios due to larger
standard errors. Using SIMEX rather than RCAL models tends to preserve precision of odds ratios.
We found in many cases that bias in naïve odds ratios was towards the null. RCAL tended to
correct for a larger amount of effect bias than SIMEX, particularly for Approach A.
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Food frequency questionnaires (FFQ) have been histori-
cally used in large epidemiological studies to assess usual
dietary intake of specific nutrients and food groups. They
have been repeatedly validated against another dietary
assessment method assumed to be more accurate such as
multiple 24-hour recalls or food records of food intake [1-
3]. The problem inherent in this approach is that the same
factors that affect these reference methods (R) may also
affect the FFQ-based assessments (Q), which include over
or under-reporting biases of subjects with certain socio-
demographic or health-related characteristics. This prob-
lem would make it impossible to presume independent
random errors in the two methods, which in turn leads to
over-estimation of the correlation between the reference
method and the FFQ [4]. Hence, to consider a method a
gold standard, it should ideally reflect the true values of
what we are trying to measure. In nutritional epidemiol-
ogy, very few biomarkers can be considered as gold stand-
ards and are often very expensive to carry out even on
relatively small samples. Alloyed gold standards are used
instead which are considered to be accurate depictions of
the truth, being unbiased in expectation. Moreover, any
error associated with them can be assumed to be random
and independent of the true unknown value of intake.
Compared to self-reports (e.g. multiple 24 hr. recalls),
biomarkers are alloyed gold standards that can addition-
ally be assumed to have independent measurement errors
from those of the test measure itself (i.e. FFQ). Such
restriction on measurement error associations makes
biomarkers a desirable target for validation studies. A
number of epidemiologic studies however, consider
repeat measures of the FFQ as alternative means to correct
for measurement error, given that biomarkers have also
some drawbacks including their associated random and
systematic error components. In fact, a previous study
favored this method over external validation in terms of
preserving the precision of estimates [5].
The present study aims first at assessing the degree of
measurement error in the intake of essential fatty acids
using a food frequency questionnaire, by estimating atten-
uation factors for each exposure. Second, we studied the
impact of correcting for such measurement error on bias
and precision of odds ratios from a multivariate logistic
regression model. For illustrative purposes, we examined
the effect of dietary essential fatty acids on clinically sig-
nificant cognitive decline among older adults, controlling
for other potential confounders. For both objectives, two
alternative approaches were used: (A) External validation
against two biomarkers measured at visit 1 among a subset
of the Atherosclerosis Risk in Communities (ARIC) study.
These concentration biomarkers are the percent of each
fatty acid or group of fatty acids out of total fatty acid con-
centration in the cholesteryl ester (M) and phospholipids
(N) fractions of plasma which were previously shown to
be linearly related to dietary intake as assessed by more
reliable reference methods such as multiple 24-hour
recalls, food records or diet history [6-8]. In fact, one study
conducted in UK (Whitehall II) showed that correlation
between 7-day food records estimated fatty acids and
cholesteryl ester concentration was 0.38 for EPA (one
major n-3 highly unsaturated fatty acid), 0.67 for linoleic
acid and 0.56 for all polyunsaturated fatty acids. The other
studies came to a similar conclusion. Hence, despite the
issue of transportability, it can be concluded that M and N
are moderately correlated with reference measures of die-
tary intake (B) Internal repeat measurement of the FFQ val-
ues at visits 2 and 3. While the former approach
eliminates the possibility of correlated errors between test
and reference method (one being a self-report and the
other a biomarker), the second approach is often more
readily available in many large cohort studies. In addition,
for the second objective, we contrasted regression calibra-
tion with another method known as simulation extrapo-
lation or SIMEX. Previous research indicated that dietary
n-3 fatty acids were suggestive of a protective effect against
cognitive aging [9-13]. Other studies of concentration
biomarkers for n-3 fatty acids indicated a similar associa-
tion [14-18]. However, a number of other reports could
not replicate these findings [19,20]. An evidence-based
report suggested a need to look for the effect of n-3 fatty
acids on cognitive decline and to define exposure in terms
of absolute value of medium chain and long chain fatty
acids, as well as the ratio between n-3 and n-6 fatty acids
in diet and plasma [21].
Findings from our study and its overall methodology may
be used in subsequent analyses to adjust for measurement
error in primary regression linking intake of essential fatty
acids with various disease outcomes.
Results
Fatty Acid Exposure Distribution
Table 1 presents the distribution of fatty acid groups and
ratios for the main study as well as the sub-samples with
complete biomarker and repeat measure data. Fatty acid
groups are expressed as % of total energy for Q1, Q2 and
Q3. For M and N, they were expressed as % of total fatty
acids in the plasma fraction. A decreasing trend in
reported consumption of groups 6P and 6 was noted. Sim-
ilarly, the ratio of reported 3H/6H declined almost line-
arly over visits 1, 2 and 3. Standard deviations of Q1 are
instrumental in interpreting results for logistic regression
model analyses.
Measurement error in fatty acid exposures: attenuation 
factors estimation with two alternative approaches
Table 2 presents the attenuation factor estimates from the
measurement error models using Approaches A (externalPage 2 of 14
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measurements Q2/Q3). Our findings suggested that atten-
uation of bivariate effects was more pronounced for
approach A with factors ranging between 0.046 for 6H
and 0.426 for 3H/6H. As for Approach B, attenuation fac-
tors ranged between 0.456 for 3P and 0.655 for 3H/6H
and 3/6. Further, a sensitivity analysis with assumed naïve
odds ratios of two for all j variables (Loge(ORnaive) = 0.693
with SE = 0.10) was conducted to get a feel of the magni-
tude in attenuation in a measure of association that is
Table 2: Attenuation factor estimates (with standard error) from the two approaches and regression calibrated odds ratio2: Bivariate 
logistic regression model; ARIC (1987–1998)1
Fatty acid groups 
and ratios j3
External validation with biomarkers (M/N) Internal repeat measurements (Q2/Q3)
Attenuation factor Standard error
 (SE )
RCAL odds ratio 
(95% CI)2
Attenuation factor Standard error
 (SE )
RCAL odds ratio 
(95% CI)2
6p 0.230 (0.020) 20.3 (11.8, 35.0) 0.605 (0.031) 3.1 (2.7, 3.7)
3p 0.090 (0.022) >100 0.456 (0.033) 4.6 (3.5, 5.9)
6H 0.046 (0.028) >100 0.653 (0.027) 2.9 (2.6, 3.2)
3H 0.408 (0.020) 5.5 (4.5, 6.6) 0.717 (0.025) 2.6 (2.4, 2.9)
6 0.269 (0.020) 13.1 (8.8, 19.7) 0.603 (0.031) 3.2 (2.7, 3.7)
3 0.353 (0.021) 7.1 (5.5, 9.2) 0.632 (0.027) 3.0 (2.6, 3.4)
3p/6p 0.251 (0.021) 15.8 (9.8, 25.6) 0.588 (0.031) 3.2 (2.8, 3.8)
3H/6H 0.426 (0.020) 5.1 (4.3, 6,1) 0.655 (0.028) 2.9 (2.5, 3.2)
3/6 0.401 (0.021) 5.6 (4.6, 6.9) 0.655 (0.024) 2.9 (2.6, 3.2)
1 Q1: Food frequency questionnaire measurement at visit 1 of fatty acid group intake as % of energy intake or ratio of n-3 to n-6 groups. M: 
biomarker of fatty acid intake in cholesteryl ester fraction of plasma; N: biomarker of fatty acid intake in phospholipids fraction of plasma; Q2: 
Repeat of Q1 measured at visit 2 among a subset of the cohort; Q3: Repeat of Q1 measured at visit 3 among the surviving baseline cohort. RCAL: 
regression calibrated estimate.
2 Naïve odds ratio assumed to be equal to 2.00 (1.64, 2.43), with Loge(odds rationaive) = βnaive = 0.693 with a SE(βnaive) = 0.100, in the following 
bivariate model: . The odds ratio is for any binary outcome (0,1) vs. fatty acid exposure expressed as a z-score 
(increase in odds of outcome for each 1 SD in fatty acid exposure). Refer to Eq. 4.1–4.4.
3 See table 2.
λˆ j λˆ j λˆ j λˆ j
E( | ) 0 (na ve, j)Y Q Qj j= +ˆ ˆβ β
Table 1: Distribution of fatty acid groups and ratios Q1, M, N, Q2 and Q3 : Mean ± SD; ARIC (1987–1995)1
Q1 M N Q2 Q3
(n = 7,814) (n = 2,251) (n = 634)
Fatty acid groups 
and ratios j2
6p 4.43 ± 1.43 55.22 ± 4.46 22.03 ± 2.59 4.29 ± 1.40 4.19 ± 1.36
3p 0.41 ± 0.09 0.41 ± 0.10 0.14 ± 0.05 0.40 ± 0.09 0.41 ± 0.10
6H 0.08 ± 0.03 9.11 ± 1.70 15.80 ± 2.10 0.07 ± 0.03 0.07 ± 0.03
3H 0.18 ± 0.16 1.01 ± 0.39 3.44 ± 1.05 0.17 ± 0.15 0.16 ± 0.15
6 4.50 ± 1.43 63.31 ± 4.01 37.73 ± 1.78 4.37 ± 1.41 4.27 ± 1.36
3 0.60 ± 0.19 1.42 ± 0.43 3.59 ± 1.05 0.57 ± 0.18 0.57 ± 0.18
3p/6p 0.10 ± 0.04 0.01 ± 0.00 0.01 ± 0.00 0.10 ± 0.02 0.11 ± 0.05
3H/6H 2.27 ± 1.87 0.11 ± 0.05 0.22 ± 0.08 2.22 ± 1.71 2.12 ± 1.69
3/6 0.15 ± 0.07 0.02 ± 0.01 0.09 ± 0.03 0.14 ± 0.07 0.15 ± 0.07
1 Q1: Food frequency questionnaire measurement at visit 1 of fatty acid group intake as % of energy intake or ratio of n-3 to n-6 groups. M: 
biomarker of fatty acid intake in cholesteryl ester fraction of plasma; N: biomarker of fatty acid intake in phospholipid fraction of plasma; Q2: Repeat 
of Q1 measured at visit 2 among a subset of the cohort; Q3: Repeat of Q1 measured at visit 3 among the surviving baseline cohort. 2(3P) n-3 C18 
polyunsaturated fatty acids: 18:3+18:4n-3 (6P) n-6 C18 polyunsaturated fatty acids: 18:2+18:3n-6 (3H) n-3 C20 and C22 highly unsaturated fatty acids 
(HUFAs): 20:5+22:5+22:6n-3 and (6H) n-6 HUFAs: 20:3+20:4+22:4+22:5n-6. Sums of fatty acid intake as percent of energy included (3) = 
(3P)+(3H) and (6) = (6P)+(6H). Ratios of interest: 3P/6P, 3H/6H and (3P+3H)/(6P+6H) also denoted as 3/6. Notation: The chemical structure of 
each fatty acid is as follows: "Total number of carbon atoms" : "# of double bonds" n-"carbon number with first double bond starting from the 
methyl end.Page 3 of 14
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4.4 (Methods section) were used for this purpose. In
many cases, approach A yielded corrected odds ratios that
were outside the reliable range (The two odds ratios dif-
fered by more than 10-folds) while approach B gave
adjusted odds ratios within a reliable range. However, fur-
ther sensitivity analysis with other values of the naïve esti-
mate of the odds ratio indicated that a value between 1.0
and 1.5 gave more reliable corrected estimates compared
to values of 1.5 or higher, particularly for approach A. It is
worth noting that these computations are only applicable
to bivariate models with one error prone variable.
Measurement error adjustment in multivariate logistic 
models: alternative approaches
Figure 1. shows a LOWESS smoothed representation of
the behavior of clinically significant cognitive decline in
verbal fluency between visits 2 and 4 in our study popula-
tion (n = 7,814) by age, stratified by sex, education and
ethnicity [22]. In general, cognitive decline was shown to
affect a greater proportion of individuals for subjects
whose baseline age was 60 years or more, and that was
particularly true for those with education exceeding high
school and among African-Americans. The same patterns
were observed when continuous cognitive change was
considered (Visit 4 – Visit 2).
As an application to multivariate logistic models, we con-
ducted further analysis using available data on cognitive
decline and essential fatty acids and controlling for rele-
vant confounders (Equations 4 and 5). Table 3 presents
naïve and corrected odds ratios for each fatty acid group/
ratio in relation to decline in WFT using two approaches
(external validation and internal repeat measurements) as
well as two measurement error correction methods (RCAL
and SIMEX). In general, the results showed that RCAL
tended to yield wider confidence intervals as compared to
SIMEX when contrasting confidence limit ratios, particu-
larly when the naïve estimate was close to the null value
of 1. The point estimate indicated bias towards the null
value of 1, when comparing the corrected to the naïve for
28 out of the 36 models that were ran. Most of the 8 asso-
ciations that did not fit this finding showed bias through
the null and had naïve odds ratios very close to the null
Locally Weighted regression (LOWESS)1 of clinically significant decline in Word Fluency Test (WFT) by age: stratified by sex, education and thnicity; ARIC 1987–1998Figure 1
Locally Weighted regression (LOWESS)1 of clinically significant decline in Word Fluency Test (WFT) by age: stratified by sex, 
education and ethnicity; ARIC 1987–1998. 1LOWESS smoother with bandwidth of 0.50.
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rected in odds ratios for each approach/method dyad was
as follows: Approach A/RCAL (|∆bias| = 0.12); Approach
A/SIMEX (|∆bias| = 0.06); Approach B/RCAL (|∆bias| =
0.08); Approach B/SIMEX (|∆bias| = 0.06). Hence, in gen-
eral, RCAL corrected for more bias than SIMEX did and
this was more obvious for Approach A.
For internal repeat measurements (Approach B), results
indicated an appreciable loss in precision, given that rep-
licate Q2 was measured for only 657 subjects out of the
7,814 who were eligible. Comparing the two approaches,
many of the unexpected results with bias through or away
from the null occurred in Approach B. In addition, in
terms of precision, approach A yielded an average for
ratios of confidence limit ratios (CLRs) of 1.22 (1.41 for
RCAL and 1.14 for SIMEX), compared to 1.62 (1.75 for
RCAL and 1.48 for SIMEX) for approach B, which indi-
cates a greater overall precision in approach A.
To illustrate graphically the SIMEX procedure that allows
for correction of the point estimate of effect (β1 =
LogeOR), Figure 2 shows a SIMEX plot of the association
between 3H (z-score) and odds of decline in WFT cor-
Table 3: Naïve and corrected odds ratios for each fatty acid group/ratio and decline in Word Fluency Test (WFT)3 using two 
approaches and RCAL/SIMEX methods: Change in estimate (∆bias) and precision (∆precision) compared to the naïve estimates; ARIC 
(1987–1998)1
Odds Ratios (95% Confidence Intervals)
Fatty acid groups and 
ratios j2
Naïve (Q1 = T) External validation with biomarkers (M/N) 
(Approach A)
Internal repeat measurements (Q2/Q3) 
(Approach B)
RCAL SIMEX RCAL SIMEX
6p 1.03 (0.93, 1.14) 0.98 (0.76, 1.25) 0.98 (0.83, 1.16) 1.04 (0.75, 1.21) 0.97 (0.80,1.18)
∆bias4 __ __ 0.05 c 0.05 c -0.01 a 0.06 c
∆precision5 __ __ 1.34 1.14 1.32 1.33
3p 1.01 (0.92, 1.12) 1.02 (0.77, 1.36) 1.01 (0.86, 1.17) 1.22 (0.90, 1.64) 1.15 (0.96,1.39)
∆bias __ __ -0.01 a 0.00 -0.21 a -0.14 a
∆precision __ __ 1.45 1.12 1.50 1.19
6H 1.18 (1.06, 1.31)* 1.63 (1.26, 2.14)* 1.34 (1.14, 1.56)* 1.19 (0.48, 2.91) 1.20 (0.56,2.56)
∆bias __ __ -0.45 a -0.16 a -0.01 a -0.02 a
∆precision __ __ 1.37 1.11 4.91 3.70
3H 0.85 (0.75, 0.96)* 0.73 (0.58, 0.90)* 0.80 (0.66, 0.96)* 0.80 (0.62, 1.04) 0.83 (0.68,1.02)
∆bias __ __ 0.12 a 0.05 a 0.05 a 0.02 a
∆precision __ __ 1.21 1.14 1.31 1.17
6 1.03 (0.97, 1.14) 1.08 (0.82, 1.41) 1.04 (0.89, 1.22) 0.96 (0.76, 1.21) 0.96 (0.81,1.15)
∆bias __ __ -0.05 a -0.01 a 0.07 c 0.07 c
∆precision __ __ 1.46 1.17 1.35 1.21
3 0.94 (0.85, 1.05) 0.71 (0.56, 0.90)* 0.80 (0.65, 0.97)* 0.85 (0.62, 1.17) 0.90 (0.73,1.11)
∆bias __ __ 0.23 a 0.14 a 0.09 a 0.04 a
∆precision __ __ 1.30 1.21 1.53 1.23
3p/6p 1.01 (0.91, 1.11) 1.03 (0.81, 1.30) 1.03 (0.88, 1.21) 1.21 (0.95, 1.53) 1.14 (0.95,1.36)
∆bias __ __ -0.02 a -0.02 a -0.20 a -0.13 a
∆precision __ __ 1.32 1.13 1.32 1.17
3H/6H 0.86 (0.76, 0.97)* 0.77 (0.64, 0.93)* 0.79 (0.65, 0.96)* 0.84 (0.65, 1.10) 0.87 (0.70,1.08)
∆bias __ __ 0.09 a 0.07 a 0.02 a -0.01 b
∆precision __ __ 1.14 1.16 1.33 1.21
3/6 0.95 (0.85, 1.06) 0.91 (0.76, 1.10) 0.92 (0.78, 1.08) 1.04 (0.85, 1.27) 1.04 (0.87,1.23)
∆bias __ __ 0.04 a 0.03 a -0.09 c -0.09 c
∆precision __ __ 1.16 1.11 1.20 1.13
1 Q1: Food frequency questionnaire measurement at visit 1 of fatty acid group intake as % of energy intake or ratio of n-3 to n-6 groups. M: 
biomarker of fatty acid intake in cholesteryl ester fraction of plasma; N: biomarker of fatty acid intake in phospholipid fraction of plasma; Q2: 
Repeat of Q1 measured at visit 2 among a subset of the cohort; Q3: Repeat of Q1 measured at visit 3 among the surviving baseline cohort; WFT: 
Word Fluency Test; RCAL: Regression Calibration; SIMEX: Simulation Extrapolation.
2 See table 3.
3 Each exposure is entered into the logistic regression model as a z-score and the outcome is binary with 1: decline and 0: no decline based on the 
reliable change index (RCI) criterion. RCI < -1.645 constitutes clinically significant decline between the two ARIC visits 2 and 4, which were 
separated by 6 years. The odds ratio is interpreted as increase in risk of cognitive decline with each 1 SD increase in the fatty acid exposure.
4 ∆bias = ORnaive - ORcorrected. a: naïve estimate is biased towards the null; b: naïve estimate is biased away from the null; c: naïve estimate is biased 
through the null. The null value for an odds ratio is 1.00.
5 ∆precision = CLRcorrected/CLRnaive. CLR or Confidence Limit Ratio is the ratio of the upper 95% confidence limit over the lower one.Page 5 of 14
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Simulation Extrapolation (SIMEX) plot of corrected coefficients for model with 3H as the exposure and Word Fluency Test (WFT) decline s the utcome: two approach s; ARIC (1987–98)1Fig re 2
Simulation Extrapolation (SIMEX) plot of corrected coefficients for model with 3H as the exposure and Word Fluency Test 
(WFT) decline as the outcome: two approaches; ARIC (1987–98)1. w: 3H; x: 6H; _cons: intercept in the model: Logit(Y = 1) = 
_cons + βnaive1Q1(3H) + βnaive2Q1(6H) where Y = decline in Word Fluency Test (WFT) based on the RCI < -1.645 criterion. 
Lambda: scale factors used to add error to the error-prone variable Q1. Error variance (needed for the SIMEX procedure) is 
estimated internally using Approach A: {Q1, M/N} or Approach B: {Q1, Q2/Q3}.
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BMC Medical Research Methodology 2007, 7:41 http://www.biomedcentral.com/1471-2288/7/41rected using both approaches A (concentration biomark-
ers M and N) and B (replicate measures of Q1: Q2 and/or
Q3). In both cases, 6H was included as an error prone con-
founder and the effect of measurement error on its associ-
ated regression coefficient is also presented. It is clear that
while approach A revealed an underestimation of the pro-
tective effect (O R< 1; β1 = Loge(OR) < 0, assuming the true
value of 1) of 3H on WFT decline by an absolute value of
0.09 between the naïve and the SIMEX coefficients,
approach B had a discrepancy of no more than 0.05. The
same difference in underestimation of adverse effect (OR
> 1; β1 = Loge(OR) > 0) is noted for 6H.
Discussion
Our main findings suggested that estimates were appreci-
ably less precise for internal repeat measurements when
compared to external validation with biomarkers. How-
ever, they gave more conservative results regarding the
association between fatty acid groups and ratio with cog-
nitive decline in WFT. For instance, based on biomarker/
RCAL results, one could conclude that a 1 SD increase in
3H (n-3 highly unsaturated fatty acids) may reduce the
odds of decline by as much as 72% or as little as 10%,
with an average of 27%. While the point estimate for the
repeat measures approach still indicated a protective effect
of 3H, both RCAL and SIMEX analyses resulted in broad
confidence intervals that crossed the null value of 1. These
findings can be contrasted with the study by Duffy and
colleagues [5], who found that repeat measurements actu-
ally lead to a better precision when compared to external
validation. This finding may be caused by an artifact of
sample size difference between Q2 (n = 634) and Q1 (n =
7,814). However, it is important to note that the main
study population differed significantly from the sub-study
with external validation data (i.e. biomarkers). In con-
trast, demographic and lifestyle differences were not as
striking for the repeat measurements sub-study, probably
due to the relative preservation of racial and ethnic diver-
sity in this sub-group. Hence, transportability of attenua-
tion factors from the validation sub-study is more
questionable for the subgroup with available biomarker
data (MN whites, n = 2,251). In addition, although loss of
precision is an issue, it may also be viewed by some as
yielding more conservative estimates of effect particularly
if this loss is not substantial, as is the case for SIMEX.
Hence, we recommend using SIMEX rather than RCAL
whether the choice is to use biomarker measures results
(Approach A) or replicate measures (Approach B). As
expected, while RCAL gave less precise estimates, how-
ever, it corrected for a larger amount of bias in odds ratios,
particularly for Approach A.
The present study is also one of the very few attempts to
estimate an attenuation factor for essential fatty acids as
exposures that can be used subsequently by other
researchers for the purpose of correcting for measurement
error in bivariate generalized linear models. The approach
used was similar to previous research [23-25]. While this
article focused on RCAL and SIMEX, other measurement
error models utilize the measurement error variance
matrix ( ), including methods with instrumental vari-
ables and maximum-likelihood methods [26]. Aside from
cognitive decline, health outcomes that have traditionally
been of interest in relation to essential fatty acids and the
balance between them include coronary heart disease
[27,28], stroke [29,30], type II diabetes [31], breast and
prostate cancer [32,33], depression [34,35], a hypercoag-
ulable profile [36,37] and COPD [38].
One major implication to measurement error, as stated
earlier, is loss of statistical power to detect an exposure-
disease association. In fact, the sample size required to
detect a specific odds ratio (e.g. OR = 2) is inflated propor-
tionally to the inverse squared attenuation factor. For
instance, if the true λj was 0.2, the sample size, calculated
by assuming that λj is equal to 0.4, should be multiplied
by 0.42/0.22 = 4 to achieve the same nominal power [39].
It is worth noting that because latent variable T (true
intake of fatty acids as % of energy intake) is on a z-score
standardized scale, the use of the attenuation factor would
lead to a calibrated standardized regression model. For a
logistic model, an odds ratio is interpreted as increase or
decrease in odds of disease with every SD increase in the
continuous z-scored exposure.
Some of the main limitations of this study include the
lack of a reference method that is known to be more reli-
able than FFQs in the ARIC study (e.g. multiple 24-hour
recalls or food records). However, because of correlated
errors between self-report methods, the use of biomarkers
has often been cited as a more adequate means to assess
the extent of measurement error in a test instrument.
Another drawback is the fact that plasma levels of fatty
acids in both fractions studied constitute a short-term
measure of intake although they have been shown to cor-
relate well with long-term intake [40]. In addition, the
lack of certainty as to the nature of the relationship
between the biomarkers considered and the intake varia-
bles and the potential interaction of these dietary expo-
sures with other nutritional, environmental and genetic
factors constitutes a major challenge for interpretation.
For this reason, and using structural equations modeling,
estimation of measurement error in FFQ derived nutrients
took into consideration two approaches, by including
repeat measurements at visit 2 and 3 of the FFQ in one
and two concentration biomarkers with assumed linear
relationship with intake in another. Finally, although
there has been evidence of correlation between intake of
ΣˆuuPage 7 of 14
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our study, such a correlation does not necessarily render
these biomarkers an adequate reflection of long-term fatty
acid intake. In fact, the only substrate that has been shown
to work as a gold standard is adipose tissue. However,
because of the elevated cost and invasiveness of the proce-
dure, studies using adipose tissue fatty acid concentration
as an intake biomarker were often of limited sample size
and hence correlations obtained had insufficient levels of
precision [41,42]. Another potentially adequate biomar-
ker that was often used to validate medium-term intake of
fatty acids is erythrocyte membrane concentration
[43,44].
Conclusion
Future endeavors to correct for error should make use of
structural equations modeling and include as many con-
centration biomarkers as is available along with other self-
reported or biomarker-based reference methods of dietary
assessment. However, the choice of biomarkers and inter-
pretation of their variability must be made as to account
for biochemical and physiological interactions between
dietary, environmental and genetic factors. Moreover, one
must be cautious of coupled errors between biological
markers and must take into account these correlations
when specifying the structural model. Finally, because
structural equations modeling makes a strong assumption
about joint multivariate normality, often not present, it is
crucial for future studies to use newly developed method-
ologies which appear to be more flexible in many ways
[45].
Methods
Study subjects
ARIC is a prospective cohort study which aimed at inves-
tigating the etiology of atherosclerosis and its clinical
sequelae and the longitudinal impact of variation in car-
diovascular risk factors, medical care, and disease by race,
sex, place, and time. In each of four US communities –
Forsyth County (NC), Jackson (MS), suburbs of Minneap-
olis (MN), and Washington County (MD) – 4,000 adults
aged 45–64 years were examined four times, three years
apart (visits 1 through 4). Three out of the four cohorts
represented the ethnic mix of their communities, while at
Jackson, MS, only African American residents were
recruited [46]. Out of the total sample examined at base-
line (N = 15,792) we restricted these analyses to 11,557
individuals aged 50 years or older at baseline. Eligibility
for these analyses further required complete data on cog-
nitive functioning at visits 2 (1990–92) and 4 (1996–98)
and also complete dietary intake at visit 1 (1987–89),
which yielded n = 7,814 men and women. Of these,
plasma fatty acid data at visit 1 was available on a sub-set
of the Minneapolis cohort, MN (n = 2,251). Additionally,
repeat measures using the same FFQ were conducted
among 657 at visit 2 and 7,482 at visit 3 of the 7,814 eli-
gible subjects who had exposure data at baseline and com-
plete outcome assessment. Repeat measures on both visits
2 and 3 were available for 634 of the eligible subjects.
Outcome assessment
Measures of cognitive functioning were made for visits 2
and 4 of the ARIC study. In our present study, we focus on
decline in Word Fluency Test (WFT). This test requires
subjects to record as many words as possible using the ini-
tial letters F, A and S and to list these words, the subject is
given only 60 seconds per letter. The total score corre-
sponds to the total number of words generated during
these three trials. The test is particularly sensitive to lin-
guistic impairment [47,48] and early mental decline in
older persons [49]. It is also a sensitive marker of damage
in the left lateral frontal lobe [47,48]. The immediate test-
retest correlation coefficient based on an alternate test
form has been found to be high (r = 0.82)[50].
Cutoff points were determined for decline in cognitive sta-
tus WFT test using the Reliable Change Index (RCI)
method in order to correct for measurement error and
practice effects [51]. RCI is defined as ((X2-X1)-(M2-M1))/
S.D., where X1 is the individual's score at baseline, X2 the
individual's score at follow-up, M1 and M2 are the group
mean pretest and follow-up scores respectively, and S.D.
the observed standard deviation of the difference scores.
Scoring below an RCI of -1.645 was regarded as a "statis-
tically reliable" deterioration in the test scores.
Error-prone dietary exposure
Usual dietary intake was estimated from an interviewer-
administered 61-item semi-quantitative food frequency
questionnaire (FFQ) previously developed and validated
by W. Willet and colleagues against multiple food records
among a sub-sample of the Nurse's Health Study cohort
[52].
In our study, dietary intake of essential fatty acids and
their elongated and desaturated products were expressed
as percent of total energy intake and grouped under four
main categories, as suggested by Lands and colleagues
[53,54]: (3P) n-3 C18 polyunsaturated fatty acids:
18:3+18:4n-3 (6P) n-6 C18 polyunsaturated fatty acids:
18:2+18:3n-6 (3H) n-3 C20 and C22 highly unsaturated
fatty acids (HUFAs): 20:5+22:5+22:6n-3 and (6H) n-6
HUFAs: 20:3+20:4+22:4+22:5n-6. Sums of fatty acid
intake as percent of energy included (3) = (3P)+(3H) and
(6) = (6P)+(6H). Ratios of interest included (3P)/(6P),
(3H)/(6H) and (3P+3H)/(6P+6H) also denoted as 3/6. In
multivariate models, all exposure variables were standard-
ized by subtracting each observation from the variable
mean and dividing the difference by the standard devia-
tion. Adjustment was made for the other fatty acid varia-Page 8 of 14
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considered as a potential confounder to emulate a multi-
variate nutrient density model [55]. While other energy
adjustment methods were possible, the latter was consid-
ered as more amenable to public health implications.
Concentration biomarkers
Twelve-hour fasting blood was collected according to the
ARIC study wide protocol. The Minneapolis field center
conducted fatty acid analysis in plasma phospholipid and
cholesteryl ester fractions for visit 1 blood specimens
(1987–89) among the white segment of the study popu-
lation in that center. The procedure is described in detail
elsewhere [38]. The identity of 28 fatty acid peaks were
revealed by gas chromatography by comparing each
peak's retention time to the retention times of fatty acids
in synthetic standards of known compositions. The rela-
tive amount of each fatty acid (as a percent of all fatty
acids) could be calculated by integrating the area under
the peak and dividing the result by the total area for all
fatty acids and multiplying by 100. To minimize transcrip-
tion errors, data from the chromatogram was transferred
electronically to a computer for analysis. Two concentra-
tion biomarkers, consisting of the plasma phospholipids
and cholesteryl ester level of fatty acids in each of the
groups described above, were used to assess measurement
error in the FFQ and correct for that error.
Repeat FFQ measures
Dietary intake was assessed among the surviving ARIC
sample at visit 3 (1992–94), using the same FFQ that was
administered at baseline. At visit 2 (i.e. 1990–92), a sub-
sample of ARIC (around 10% of the original sample) was
asked to repeat the FFQ, unlike visits 1 and 3 in which the
whole ARIC sample was covered. As stated earlier, of our
eligible subset with baseline data on exposure and com-
plete outcome data (n = 7,814), 657 had data on visit 2
exposure, 7,482 had complete data at visit 3, while 634
had both.
Covariates
Most covariates considered as potential confounders were
measured at visits 1 or 2. These included sociodemo-
graphics (age, gender, ethnicity, education), genetic (Apo
E ε4 carrier status), behavioral (smoking, alcohol and caf-
feine consumption and physical activity), nutritional
(body mass index, intake of antioxidants and other micro-
nutrients mainly Vitamins B6, B12 and folate). All these
were previously shown to be independently predictive of
the outcome and associated with our exposure. The distri-
butions of these covariates within each sub-sample con-
sidered are presented in Table 4.
Statistical analysis
(1) Bivariate scenario: estimation of attenuation factors. In
this part, each essential fatty acid using the two alternative
approaches and a structural equations modeling tech-
nique. (2) Multivariate scenario: regression calibration
and Simulation Extrapolation. In this part, the association
between essential fatty acid intake and clinically signifi-
cant decline in WFT as an outcome was studied and
adjusted for measurement error in exposures. We exam-
ined changes in 95% CI and point estimates after correc-
tion for error using alternative approaches and methods.
(1) Bivariate scenario: estimation of attenuation factors
Estimating the attenuation factor associated with the
effect of each exposure variable or covariate on an out-
come constitutes the first step for measurement error
adjustment using regression calibration. In our example,
and for attenuation factor estimation, the structural mod-
els were considered for each of the two approaches (Eq. 1
and 2).
Approach A
Approach B
This set of equations allowed us to estimate the attenua-
tion factor λj with its approximate SE, using the delta
method (Eq. 3).
when Var(Q1) = Var(T) = 1. This is the case when all meas-
ured variables (Qk, M, N) are standardized z-scores.
The lower the attenuation factor, the higher the measure-
ment error in the error-prone exposure variable. λj = 1
if there is no measurement error or Q1 = T.
Assuming non-differential misclassification, dietary
measurement error often attenuates diet-disease relation-
ship and thus biases the effect towards the null. The
amount by which the association is biased can be esti-
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and colleagues [56], if a primary regression model (Eq.
4.1) with a response variable Y contains only one error-
prone explanatory variable Qj (bivariate scenario) correc-
tion for attenuation, consists simply of dividing the
regression coefficient β(naïve, j) of that variable Qj by the
attenuation factor λj (Eq. 4.2). The variance estimates for
the corrected regression coefficient of effect as well as 95
percent CI are estimated using Eqs. 4.3.1, 4.3.2 and 4.4.
Q1ij and biomarkers Mij and Nij are entered into the model
as z-scored variables. The same applies to the repeat meas-
ures Q2ij and Q3ij. Note that Q1ij is the manifest variable
denoting visit 1 dietary exposures, which are the test expo-
sures of interest (n = 7,814).
For logistic regression, the assumptions made are linear
homoscedastic regression of T on Q with a normally dis-
tributed error term and a rare disease requirement [56].
Subsequently Kuha [57] introduced two key requirements
for approximate unbiasedness of βRC : (i) β21 * σ2 product
E( | ) 0 (na ve, j)Y Q Qj j= +ˆ ˆβ β (4.1)
ˆ ˆ ˆβ β λ(RC, j) (naïve, j) j / = (4.2)
Var( )
Var( )/ Var(
(RC, j)
(na ve, j) (na ve, j)
2
j
ˆ
ˆ ˆ ˆ ˆ
β
β λ β λ
=
+j
2 )/  λˆ j4
(4.3.1)
SE( ) Var( )(RC, j) (RC,j)ˆ ˆβ β= (4.3.2)
95 percent CI 
1.96 SE( )
(RC, j) 
(RC, j) (RC, j)
β
β β
≡
ˆ ˆ± ×
(4.4)
Table 4: Baseline characteristics for subgroups (data on Q1, additional data on biomarkers M/N, and on replicates Q2 and Q3); ARIC, 
1987
Q1 (n = 7,814) Q1, M and N (n = 2,251) Q1, Q2 and Q3 (n = 634)
n % n % n %
White 6,387 81.5 2,251 100* 501 79.0
Female 4,269 54.6 1,141 50.7* 293 46.2*
Age(years)
50–54 2,904 37.2 896 39.8* 179 28.2*
55–59 2,619 33.5 743 33.0 247 38.9
60+ 2,291 29.3 612 27.2 208 32.8
Education
Less than High school 1,580 20.2 150 6.7* 141 22.3
High school graduate 2,658 34.1 814 36.2 189 29.9
More than High school 3,567 45.7 1,286 57.2 303 47.9
Apo E ε4 allele 2,249 30.0 614 28.8 164 27.0
Body Mass Index (kg per m2)
<25.00 2,596 33.2 760 33.8* 220 34.7
25.0–29.9 3,220 41.2 962 42.8 274 43.2
≥ 30 1,995 25.5 528 23.5 140 22.1
Smoking status
Current smoker 1,555 19.9 400 17.8* 136 21.4
Former smoker 2,776 35.5 941 41.8 227 35.8
Never smoked 3,478 44.5 909 40.4 271 42.7
Mean (SD) Mean (SD) Mean (SD)
Alcohol (g/d) 5.9 (12.7) 8.1 (13.5)* 5.6 (11.2)
Caffeine (mg/day) 291.04 (290.82) 348.08 (325.93)* 313.36 (297.42)*
Physical activity scale 7.06 (1.39) 7.33 (1.33)* 7.10 (1.48)
Energy intake (kcal/day) 1578 (571) 1581 (559) 1620 (566)
Vitamin A (1000 IUs/day) 9.1 (7.0) 8.6 (6.8)* 9.2 (7.3)
Vitamin B6 (mg/day) 1.75 (0.67) 1.74 (0.66) 1.75 (0.68)
Vitamin B12 (mcg/day) 7.61 (4.23) 7.06 (3.50)* 7.97 (4.32)*
Vitamin C (mg/day) 122 (81) 113 (70)* 122 (86)
Vitamin E (mg/day) 5.0 (3.1) 4.7 (3.0)* 5.1 (3.4)
Folate (mcg/day) 232.59 (101.18) 218.48 (94.97)* 235.03 (102.66)
*p < 0.05 for hypothesis that the distribution of the categorical variables is independent of the group or that mean in (Q1) group is equal to mean 
in each of the other group for continuous variables.Page 10 of 14
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and f(T|Q) is normal.
In cases where more than one error-prone variable and
several perfectly measured variables are introduced into a
primary regression model (5), the attenuation factor is no
longer the parameter to be used for calibration.
(2) Multivariate scenario: regression calibration and simulation 
extrapolation
For the multivariate scenario, we computed odds ratios of
clinically significant decline in WFT (RCI < -1.645) with
increase in each exposure by 1 SD through a multivariate
logistic regression analysis. Control for confounding was
accomplished using backward elimination whereby cov-
ariates that changed the estimated effect of the exposure
by more than 5% were retained in the final model [58].
The parsimonious model which provided a non-con-
founded estimate of the effect of a fatty acid exposure on
the outcome (decline in WFT over a period of six years: a
binary variable) was represented as the naïve estimate of
effect. Subsequently, regression calibration and simula-
tion extrapolation were conducted on this same parsimo-
nious model, as alternative methods for two approaches
(A and B) described earlier.
Under such a multivariate scenario, regression calibration
becomes reliant on the variance-covariance matrix of error
in the measurement of different error-prone variables Qj
( ) as well as the variance-covariance matrices of the
variables themselves. This relationship termed "method
of moments" can be summarized in equation (6) [26].
The detailed explanations of each moment is laid out in
equations 7.1 through 7.5 [59], and table 5.
Example: FFQ visit 1 z-score for fatty acid exposures (Q1)
are error-prone variables and have at most two replicates:
1 ≤ k ≤ 3 for each observation. Z (e.g. age) is available for
all observations and is not error-prone.
k replicates for each individual i. W = {Q1, Q2/Q3} or {Q1,
M/N}.
Alternatively, one can use simulation extrapolation
(SIMEX) which also relies on the method of moments
with an estimate of  or replicate measures of the error-
prone variable. This method can be summarized as fol-
lows[60]:
Step 1 : Simulation step:
• Create additional datasets with increasingly larger
amounts of measurement error, after estimating error var-
iance for each error-prone variable ( ):
(1 + θ)  with: θ = {0.5,1.0,1.5,2.0}
Varθ (Q) = Var(T) + ( 1 + θ)
• Regression coefficients estimated using method of
moments (Eq. 6–7.5)
Step 2: Extrapolation step:
After plotting each of the estimated coefficients with θ =
{0.5,1.0,1.5,2.0}on the x-axis, the coefficient βT, SIMEX is
E( | Z ) Z0 T,na ve, Z
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where covariate Q becomes error-free,
Var(T) = Var-1(Q) + (1 + -1)  = Var-1(Q)
Step 3: Variance and SE of the regression coefficients for
SIMEX point estimates are estimated either with an
asymptotic or bootstrap method.
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